The illuminati has been trying to poison us with anti-biotics in our meat supply. 70% of the antibiotics that are sold in the US are sold to be fed to animals. The animals are given antibiotics daily because they are living in horrible unsanitary conditions that expose them to disease all the time.

Having all of the antibiotics in our food supply is creating super bacteria that are not responsive to the antibiotics we have. This is one of the biggest health problems in America. It is also a global problem since the bacteria can go anywhere in the world once they evolve in the US. In Europe and most of the developed world, you are not allowed to give domestic livestock antibiotics. Only in America is this still allowed.

The CDC estimates that 1 in 5 antibiotic-resistant infections in humans are caused by germs from food and animals. The antibiotics we rely on to treat salmonella, campylobacter and other relatively-common food-borne pathogens, are less effective than they used to be. The bacteria are getting stronger, so the infections they cause are more difficult to treat. The problem, in part, goes back through the food chain to how we raise the meat we eat.

Approximately 70 percent of medically-important antibiotics sold in the U.S. go to livestock and poultry operations. Meat producers often give routine doses of antibiotics to animals that aren't sick to compensate for unsanitary and overcrowded conditions. The unintended consequence of that practice is the rise and spread of drug-resistant -- and resourceful -- bacteria. They make their way into communities via farm workers or contaminated meat, or through environmental pathways such as water run-off and airborne dust. Also, when farmers use manure from animals to treat fields growing produce, antibiotic-resistant bacteria can contaminate the produce, which unsuspecting consumers then might put into a nice salad.

The overuse of antibiotics in meat production and its contribution to drug-resistant bacteria has been documented for decades. Dr. Stuart Levy conducted a landmark study in the 1970s that established the link between routine antibiotic use on farms and the presence of drug-resistant bacteria in people. A 2013 study found that the closer people lived to industrial farms, the higher the likelihood they'd contract MRSA infections. The study concluded that "these findings contribute to the growing concern about the potential public health impacts of high-density livestock production." The list of evidence goes on and on.

Tuberculosis. Malaria. Syphilis. Gonorrhea. The microbes that cause these diseases are increasingly resistant, and sometimes even impervious, to antibiotics that worked in the past. Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society. All of this is because of all the antibiotics we flood into our livestock and the rise of antibiotic resistant superbugs.

Not only are exististing bacteria and diseases mutating, we are also finding new bacteria that are superbugs that are completely antibiotic resistant. This is not a theoretical issue, every year we are discovering more antibiotic resistant bacteria. These superbug bacteria usually strike patients whose immune systems are weak. Once they take hold, they are virtually unstoppable and victims usually die.

The British National Health Service may soon be unable to safely offer caesareans and hip operations because of soaring levels of antibiotic resistance in British hospitals, the chief medical officer for England has warned.

In a future with superbugs, "common infections and minor injuries kill once again, and the types of intervention we routinely deliver today, such as caesarean sections, chemotherapy and hip replacements, become extremely dangerous", Sally Davies writes in the Daily Telegraph.

"What is at stake here is nothing less than the basic integrity of modern medicine – and without this, quite simply, we, our children, and our grandchildren have nothing".

A 2016 report on the growing global threat of antibiotic resistance by former Goldman Sachs boss, Lord O'Neill, warned that, if left unchecked, superbugs could kill 100m people around the world by 2050.

Earlier this year, Public Health England revealed that an English traveller had picked up a case of "super gonorrhea" in south east Asia which was resistant to all standard antibiotics. The sexually transmitted infection was only cured after three days of intravenous treatment with the antibiotic of last resort, ertapenem.

This bug and others are spreading rapidly across the globe fueled by the overuse of antibiotics in medicine, especially in developing countries like India, and their use as a prophylactic and growth promoter in factory farms across the world.

Although many resistant superbugs may start abroad, the nature of the connected modern world means they quickly infect other health systems and populations. For example, the south east Asian "super gonorrhea" spread to Australia as well as the UK.

Strains can even vary within hospitals.

For example, the antibiotics used in a transplant unit often differ from those used in neonatal intensive care, so different resistant bacteria may circulate, said Dr. William Schaffner, head of preventive medicine at Vanderbilt University Medical Center.

Infants in eastern Tennessee, he said, had more antibiotic-resistant ear infections than those in the state's western half or in many other states. Doctors there are "exuberant prescribers," he said, which drives antibiotic resistance.

Resistance to carbapenems, which had been reliable "last line of defense" drugs, has developed recently among pathogens, as a gene first found in India in 2008 — and named NDM, for New Delhi metallo-beta-lactamase — spread around the world.

The latest last-ditch antibiotic to start failing is colistin, which was invented in 1959 but shelved because it caused kidney damage. Chinese pig farmers adopted it and feed nearly 12,000 tons to their pigs each year to speed their growth.

Drug-resistant strains were first found in China in 2015, with a disturbing aspect: the resistance-conferring gene was not in the bacteria's own DNA but on a plasmid, a small DNA ring that can jump from one bacterial species to another. The Chinese study found it in 21 percent of pigs sampled, and 1 percent of hospitalized humans. The first American patient with it was found last year.

Colistin resistance "sent shock waves through the medical and scientific communities," Dr. Margaret Chan, the W.H.O.'s director general, said last year. "If we lose colistin, as several experts are predicting, we lose our last medicine for a number of serious infections."

We don't have enough time to find new antibiotics to replace the ones we have. New antibiotic candidates are in short supply, because 70 years of research have made it harder to find new ones, and because they are not very profitable for pharmaceutical companies.

Last November, the World Health Organization recommended completely restricting the use of antibiotics on otherwise healthy animals. It's unclear if the U.S. government will respond accordingly. U.S. Food and Drug Administration (FDA) commissioner Scott Gottlieb recently commented that the agency would be releasing a plan in the coming months to combat superbugs in the food supply. So far, the FDA has taken half measures to address a problem that poses potentially-catastrophic consequences for modern medicine.

To make matters worse, drug companies are pushing for a proposal that would expand conditional approvals of drugs, through a piece of legislation known as the Animal Drug User Fee Act (ADUFA). Doing so would allow the companies to market drugs, including antibiotics, for use in animals without proving that they're effective. That could encourage more antibiotic use and increase the risk of drug-resistant bacteria spreading through the food supply, with no guarantee that the drugs will work as intended. The risk is not worth the reward, especially since the drug makers wouldn't have to demonstrate a reward in the first place.

Health professionals across the country have expressed their concerns about expanding conditional approvals, citing the risk of antibiotic resistance. The bottom line is: the more we use antibiotics, the less they work. Lawmakers should pass policy that reduces antibiotic use on farms, rather than giving pharmaceutical companies a boost to increase drug sales.